Doctor profile · Federal record
Dr. Philip Philip, MD PHD FRCP
Medical Oncology Physician (CMS: Hematology/Oncology) · Internal Medicine Physician · Detroit, MI
- NPI 1316985484
- Accepts Medicare
- 49 yrs in practice
- Male
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
4100 John R Hwcrc 4Th Fl, Karmanos Cancer Center
Detroit, MI 482012013
(800) 527-6266
fax (313) 576-8767 - Mailing address
-
1560 E Maple RD, Suite 400-Credentialing
Troy, MI 480831138
Credentials & registration
- NPI registered
- June 2006 — 20 yrs on file
- Profile last updated
- October 27, 2016
- Year of graduation
- 1977 — 49 yrs since
- Specialty taxonomy
- 207RX0202X — NUCC code
- State license (1)
- Michigan #4301066240
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1316985484. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
103
Distinct HCPCS
4
Medicare allowed
$13,569
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 41 | 32 | $144 | |
99215 |
Established patient office or other outpatient visit, 40-54 minutes | 33 | 20 | $145 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 15 | 12 | $99 | |
99214 |
Established patient office or other outpatient visit, 30-39 minutes | 14 | 13 | $99 |
In context: peer comparison
Among 4 peers in Detroit Medical Oncology Physician, average services per provider: 57. This provider delivers 1.8× the peer median.Open Payments
Industry payments received
All-time total
$76,406
Transactions
67
Manufacturers
13
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Incyte Corporation | 20 | $18,329.96 | |
| Astellas Pharma US INC | 15 | $17,220.88 | |
| BioNTech Se | 8 | $16,454.21 | |
| Takeda Pharmaceuticals U.S.A., INC. | 7 | $10,008.52 | |
| Ipsen Biopharmaceuticals, INC | 6 | $4,264.76 | |
| Bayer Healthcare Pharmaceuticals INC. | 2 | $3,687.50 | |
| Fosun Pharma USA INC. | 2 | $2,587.29 | |
| Mirati Therapeutics, INC. | 1 | $2,450.00 | |
| Pfizer INC. | 2 | $1,006.22 | |
| Genentech USA, INC. | 1 | $164.27 | |
| Eisai INC. | 1 | $118.42 | |
| AstraZeneca Pharmaceuticals Lp | 1 | $60.77 | |
| Novocure INC. | 1 | $53.42 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
24
Patients
0
Total drug cost
$7,646
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Eliquis (Apixaban) | Brand | 13 | 0 | $7,423 |
| Loperamide (Loperamide Hcl) | Brand | 11 | 0 | $223 |
Hospital affiliations
Frequently asked questions
What is Dr. Philip Philip's medical specialty?
Dr. Philip Philip practices Medical Oncology Physician in Detroit, MI.
Where does Dr. Philip Philip practice?
Dr. Philip Philip practices at 4100 John R Hwcrc 4Th Fl, Detroit, MI 482012013. Office phone: 8005276266.
What is Dr. Philip Philip's NPI?
Dr. Philip Philip's National Provider Identifier (NPI) is 1316985484, issued by NPPES.
Does Dr. Philip Philip accept Medicare assignment?
Yes. Dr. Philip Philip accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Philip Philip commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99215); Established patient office or other outpatient visit (HCPCS 99214). Source: CMS Medicare Physician & Other Practitioners file.